These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 8760420)

  • 41. Experimental infection of goats with parainfluenza virus type 3.
    Afshar A; Terlecki S
    Zentralbl Veterinarmed B; 1979 Oct; 26(8):641-51. PubMed ID: 230666
    [No Abstract]   [Full Text] [Related]  

  • 42. Incomplete replication of human parainfluenza virus type 4 in LLC-MK2 cells and in L929 cells.
    Komada H; Inoue H; Yamabayashi C; Ito M; Kawano M; Nishio M; Tsurudome M; Kozuka Y; Noda N; Namba K; O'Brien M; Ito Y
    Med Microbiol Immunol; 2000 Jun; 188(4):185-9. PubMed ID: 10917155
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Transformation of Human and Animal Tissues after Virus Infection [Summary].
    Stoker M
    Proc R Soc Med; 1963 Apr; 56(4):251-2. PubMed ID: 19994213
    [No Abstract]   [Full Text] [Related]  

  • 44. Transformation of Human and Animal Tissues after Virus Infection [Summary].
    Paul J
    Proc R Soc Med; 1963 Apr; 56(4):251. PubMed ID: 19994214
    [No Abstract]   [Full Text] [Related]  

  • 45. Correlation of viral loads in disease transmission could affect early estimates of the reproduction number.
    Harris T; Geard N; Zachreson C
    J R Soc Interface; 2023 May; 20(202):20220827. PubMed ID: 37132229
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cross-protective antibodies against common endemic respiratory viruses.
    Cabán M; Rodarte JV; Bibby M; Gray MD; Taylor JJ; Pancera M; Boonyaratanakornkit J
    Nat Commun; 2023 Feb; 14(1):798. PubMed ID: 36781872
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Initial Inoculum and the Severity of COVID-19: A Mathematical Modeling Study of the Dose-Response of SARS-CoV-2 Infections.
    Fain B; Dobrovolny HM
    Epidemiologia (Basel); 2020 Oct; 1(1):5-15. PubMed ID: 36417207
    [TBL] [Abstract][Full Text] [Related]  

  • 48. AdAPT-001, an oncolytic adenovirus armed with a TGF-β trap, overcomes
    Larson C; Oronsky B; Reid T
    Am J Cancer Res; 2022; 12(7):3141-3147. PubMed ID: 35968324
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Factors Limiting the Translatability of Rodent Model-Based Intranasal Vaccine Research to Humans.
    Cai L; Xu H; Cui Z
    AAPS PharmSciTech; 2022 Jul; 23(6):191. PubMed ID: 35819736
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Infectious Salmon Anemia Virus Shedding from Infected Atlantic Salmon (
    Weli SC; Bernhardt LV; Qviller L; Dale OB; Lillehaug A
    Viruses; 2021 Sep; 13(9):. PubMed ID: 34578351
    [No Abstract]   [Full Text] [Related]  

  • 51. Protective antibodies against human parainfluenza virus type 3 infection.
    Boonyaratanakornkit J; Singh S; Weidle C; Rodarte J; Bakthavatsalam R; Perkins J; Stewart-Jones GBE; Kwong PD; McGuire AT; Pancera M; Taylor JJ
    MAbs; 2021; 13(1):1912884. PubMed ID: 33876699
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Exploring the impact of inoculum dose on host immunity and morbidity to inform model-based vaccine design.
    Handel A; Li Y; McKay B; Pawelek KA; Zarnitsyna V; Antia R
    PLoS Comput Biol; 2018 Oct; 14(10):e1006505. PubMed ID: 30273336
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Crossing the scale from within-host infection dynamics to between-host transmission fitness: a discussion of current assumptions and knowledge.
    Handel A; Rohani P
    Philos Trans R Soc Lond B Biol Sci; 2015 Aug; 370(1675):. PubMed ID: 26150668
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Methods of modelling viral disease dynamics across the within- and between-host scales: the impact of virus dose on host population immunity.
    Steinmeyer SH; Wilke CO; Pepin KM
    Philos Trans R Soc Lond B Biol Sci; 2010 Jun; 365(1548):1931-41. PubMed ID: 20478888
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pathogenesis of human parainfluenza virus 3 infection in two species of cotton rats: Sigmodon hispidus develops bronchiolitis, while Sigmodon fulviventer develops interstitial pneumonia.
    Porter DD; Prince GA; Hemming VG; Porter HG
    J Virol; 1991 Jan; 65(1):103-11. PubMed ID: 1845878
    [TBL] [Abstract][Full Text] [Related]  

  • 56. African green monkeys provide a useful nonhuman primate model for the study of human parainfluenza virus types-1, -2, and -3 infection.
    Durbin AP; Elkins WR; Murphy BR
    Vaccine; 2000 May; 18(22):2462-9. PubMed ID: 10738104
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Recombinant type 5 adenoviruses expressing bovine parainfluenza virus type 3 glycoproteins protect Sigmodon hispidus cotton rats from bovine parainfluenza virus type 3 infection.
    Breker-Klassen MM; Yoo D; Mittal SK; Sorden SD; Haines DM; Babiuk LA
    J Virol; 1995 Jul; 69(7):4308-15. PubMed ID: 7769692
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Parainfluenza virus infection among adults hospitalized for lower respiratory tract infection.
    Marx A; Gary HE; Marston BJ; Erdman DD; Breiman RF; Török TJ; Plouffe JF; File TM; Anderson LJ
    Clin Infect Dis; 1999 Jul; 29(1):134-40. PubMed ID: 10433576
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Semi-permissive replication and functional aspects of the immune response in a cotton rat model of human parainfluenza virus type 3 infection.
    Ottolini MG; Porter DD; Hemming VG; Hensen SA; Sami IR; Prince GA
    J Gen Virol; 1996 Aug; 77 ( Pt 8)():1739-43. PubMed ID: 8760420
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.